Carbocaine 2% with Neo-Cobefrin and Ibritumomab Intravenous
Determining the interaction of Carbocaine 2% with Neo-Cobefrin and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: levonordefrin / mepivacaine
Brand name: Carbocaine 2% with Neo-Cobefrin, Polocaine Dental, Scandonest 2% L
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbocaine 2% with Neo-Cobefrin-Ibritumomab Tiuxetan
- Carbocaine 2% with Neo-Cobefrin-Ibrutinib
- Carbocaine 2% with Neo-Cobefrin-Ibrutinib Capsules
- Carbocaine 2% with Neo-Cobefrin-Ibrutinib Tablets
- Carbocaine 2% with Neo-Cobefrin-Ibu
- Carbocaine 2% with Neo-Cobefrin-IBU Tablets
- Ibritumomab Intravenous-Carbocaine HCl
- Ibritumomab Intravenous-Carbocaine Injection
- Ibritumomab Intravenous-Carbocaine Preservative-Free
- Ibritumomab Intravenous-Carbocaine with Neo-Cobefrin
- Ibritumomab Intravenous-Carbofed DM
- Ibritumomab Intravenous-Carbogen